O
CCRN icon

OppenheimerFunds’s Cross Country Healthcare CCRN Stock Holding History

OppenheimerFunds’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$404K Buy
57,496
+4,331
+8% +$37.1K ﹤0.01% 1445
2018
Q4 		$390K Sell
53,165
-7,682
-13% -$64.4K ﹤0.01% 1470
2018
Q3 		$531K Buy
60,847
+15,660
+35% +$160K ﹤0.01% 1419
2018
Q2 		$508K Buy
45,187
+753
+2% +$8.98K ﹤0.01% 1419
2018
Q1 		$494K Sell
44,434
-60
-0.1% -$752 ﹤0.01% 1402
2017
Q4 		$568K Sell
44,494
-2,273
-5% -$30K ﹤0.01% 1449
2017
Q3 		$666K Sell
46,767
-551
-1% -$6.9K ﹤0.01% 1380
2017
Q2 		$611K Buy
47,318
+4,183
+10% +$53.9K ﹤0.01% 1413
2017
Q1 		$619K Buy
43,135
+8,748
+25% +$129K ﹤0.01% 1405
2016
Q4 		$537K Buy
34,387
+2,427
+8% +$33.2K ﹤0.01% 1349
2016
Q3 		$376K Buy
31,960
+5,832
+22% +$76.8K ﹤0.01% 1397
2016
Q2 		$364K Sell
26,128
-3,111
-11% -$41.2K ﹤0.01% 1381
2016
Q1 		$340K Buy
29,239
+6,842
+31% +$86.9K ﹤0.01% 1396
2015
Q4 		$367K Buy
+22,397
New +$356K ﹤0.01% 1426

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BSP
Benefit Street Partners New York $69.6M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

OppenheimerFunds's CCRN Position: Q1 2019 in Review

OppenheimerFunds increased its Cross Country Healthcare (CCRN) stake by 8.1% in Q1 2019, buying an estimated $37.1K and bringing the position to 57,496 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

OppenheimerFunds first reported a position in CCRN in Q4 2015 and has held it in 14 quarters since. The position peaked at $666K in Q3 2017. 131 funds tracked by Wall St. Rank hold CCRN as of Q1 2019.

  • OppenheimerFunds held 57,496 shares of Cross Country Healthcare worth $404K as of Q1 2019.
  • OppenheimerFunds bought 4,331 Cross Country Healthcare shares in Q1 2019, an estimated $37.1K.
  • Cross Country Healthcare made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1445 holding.
  • OppenheimerFunds first reported a position in Cross Country Healthcare in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Cross Country Healthcare position peaked at $666K in Q3 2017.
  • 131 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.